Mechanism of the rejection of major histocompatibility complex class I-disparate murine skin grafts: rejection can be mediated by CD4+ cells activated by allo-class I + II antigen in CD8+ cell-depleted hosts.
Open Access
- 1 August 1992
- journal article
- Published by Rockefeller University Press in The Journal of Experimental Medicine
- Vol. 176 (2) , 617-621
- https://doi.org/10.1084/jem.176.2.617
Abstract
In the preceding article, we analyzed the immunohistochemical rejection mechanism of major histocompatibility complex (MHC) class I (H-2K)-disparate murine skin grafts, and showed that only CD8+ cells infiltrated at the site of the epithelial tissue of MHC class I-disparate graft. We also showed that perfect survival of MHC class I-disparate grafts were attained in thymectomized recipients treated with anti-Lyt-2 monoclonal antibody. In this report, we showed that these long-surviving allo-class I grafts were rejected in the absence of CD8+ cells by stimulation with allo-MHC class I + II-disparate graft as the second stimulation. Furthermore, it was immunohistochemically revealed that under that condition, a large number of CD4+ cells infiltrated into the epithelial tissue of these long-surviving class I grafts, which were going to be rejected 2-5 d after the transplantation of a second graft with MHC class I + II difference. This result directly shows that CD4+ cells are able to became effectors for the rejection of allo-MHC class I (H-2K) skin graft.Keywords
This publication has 20 references indexed in Scilit:
- Cellular basis of skin allograft rejection across a class I major histocompatibility barrier in mice depleted of CD8+ T cells in vivo.The Journal of Experimental Medicine, 1991
- Differential involvement of CD4+ cells in mediating skin graft rejection against different amounts of transgenic H-2K(b) antigen.The Journal of Experimental Medicine, 1991
- Induction of anti-allo-class I H-2 tolerance by inactivation of CD8+ helper T cells, and reversal of tolerance through introduction of third-party helper T cells.The Journal of Experimental Medicine, 1990
- Characterization of a CD4(L3T4)-Positive Cytotoxic T Cell Clone that is Restricted by Class I Major Histocompatibility Complex Antigen on FBL-3 Tumor CellImmunobiology, 1989
- Effector cells in allelic H-2 class I-incompatible skin graft rejection.The Journal of Experimental Medicine, 1987
- Analysis of T-cell subsets in rejection of Kb mutant skin allografts differing at class I MHCNature, 1986
- Properties of purified T cell subsets. II. In vivo responses to class I vs. class II H-2 differences.The Journal of Experimental Medicine, 1986
- Therapy with monoclonal antibodies by elimination of T-cell subsets in vivoNature, 1984